Physician profile
Robert Earl Ellis
NPI 1154415370
$2,058.48
in general payments reported to CMS, 2019-2025
17 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $281 · 2021: $248 · 2022: $227 · 2023: $425 · 2024: $203 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $521.13 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $418.64 | 2022-2025 | Infuse |
| Alcon Vision LLC | $323.29 | 2019-2025 | Rocklatan, Rhopressa, Simbrinza |
| Mallinckrodt Hospital Products INC. | $143.93 | 2023 | Acthar |
| Tarsus Pharmaceuticals, INC. | $119.64 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $95.08 | 2019 | |
| Eyevance Pharmaceuticals LLC | $85.80 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $75.22 | 2019-2021 | |
| Oyster Point Pharma, INC. | $57.43 | 2023-2024 | Tyrvaya, Ryzumvi |
| Aerie Pharmaceuticals, INC. | $40.08 | 2020-2021 | |
| Glaukos Corporation | $38.51 | 2022 | |
| Carl Zeiss Meditec, INC. | $37.84 | 2019 | |
| Abbvie INC. | $32.39 | 2025 | |
| Plexus Optix, INC. | $19.86 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.52 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.25 | 2021 | |
| Coopervision INC. | $15.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.